Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukasz Bialkowski

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Adjuvant-Enhanced mRNA VaccinesLukasz Bialkowski, Kevin Van der Jeught, Dries Renmans, et al.
International Journal of Cancer|February 22, 2018
Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapyLukasz Bialkowski, Kevin Van der Jeught, Sanne Bevers, et al.
Oncotarget|October 23, 2014
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunityKevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, et al.
Oncotarget|February 16, 2015
Targeting the tumor microenvironment to enhance antitumor immune responsesKevin Van der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, et al.
Scientific Reports|March 3, 2016
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursLukasz Bialkowski, Alexia van Weijnen, Kevin Van der Jeught, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2022
Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumorsNicolas Çuburu, Lukasz Bialkowski, Sergio M Pontejo, et al.
Cancer Immunology Research|December 15, 2015
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic CellsSandra Van Lint, Dries Renmans, Katrijn Broos, et al.
ACS Nano|September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory SafetyKevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Adjuvant-Enhanced mRNA VaccinesLukasz Bialkowski, Kevin Van der Jeught, Dries Renmans, et al.
International Journal of Cancer|February 22, 2018
Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapyLukasz Bialkowski, Kevin Van der Jeught, Sanne Bevers, et al.
Oncotarget|October 23, 2014
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunityKevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, et al.
Oncotarget|February 16, 2015
Targeting the tumor microenvironment to enhance antitumor immune responsesKevin Van der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, et al.
Scientific Reports|March 3, 2016
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursLukasz Bialkowski, Alexia van Weijnen, Kevin Van der Jeught, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2022
Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumorsNicolas Çuburu, Lukasz Bialkowski, Sergio M Pontejo, et al.
Cancer Immunology Research|December 15, 2015
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic CellsSandra Van Lint, Dries Renmans, Katrijn Broos, et al.
ACS Nano|September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory SafetyKevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
Pageof 1